pharma · Clostridium Difficile Infection · Ulcerative Colitis · MCRB
Seres Therapeutics
Seres Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Cambridge, USA HQ
2010 Founded
129 Employees
Public company Type
MCRB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 129
- Programs
- 8
- Drugs
- 7
- Patents
- 36
Seres Therapeutics projects
2 ClinicalTrials.gov programs sponsored by Seres Therapeutics.
Seres Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Seres Therapeutics have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.